Scholz, Holger http://orcid.org/0000-0002-8383-040X
Boivin, Felix J. http://orcid.org/0000-0003-2325-0830
Schmidt-Ott, Kai M. http://orcid.org/0000-0002-7700-7142
Bachmann, Sebastian
Eckardt, Kai-Uwe http://orcid.org/0000-0003-3823-0920
Scholl, Ute I. http://orcid.org/0000-0002-0309-8045
Persson, Pontus B. http://orcid.org/0000-0003-0926-2878
Article History
Accepted: 5 January 2021
First Online: 5 February 2021
Competing interests
: K.-U.E. reports personal fees from Akebia, Astellas and Bayer, grants from Astra Zeneca, Bayer and Vifor. P.B.P. advises for Bayer regarding renal safety and has received funding from Bayer. The other authors declare no competing interests.